Page last updated: 2024-08-21

acridines and Thrombopenia

acridines has been researched along with Thrombopenia in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (75.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adamson, PC; Arndt, C; Balis, FM; Berg, SL; Blaney, SM; Blatt, J; O'Brien, M; Poplack, DG	1
Heilbrun, LK; Kraut, M; LoRusso, P; Philip, PA; Shields, AF; Vaitkevicius, V; Zalupski, MM	1
King, GW; Kraut, EH; Kuebler, JP; Moore, T; Triozzi, P	1
Amphlett, NW; Hadley, AG; Lucas, GF; Poole, GD	1

Trials

3 trial(s) available for acridines and Thrombopenia

Article	Year
Phase I trial and pharmacokinetic study of pyrazoloacridine in children and young adults with refractory cancers. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:1 Topics: Acridines; Adolescent; Adult; Antineoplastic Agents; Child; Child, Preschool; Drug Administration Schedule; Female; Humans; Infant; Infusions, Intravenous; Male; Neoplasms; Neutropenia; Pyrazoles; Thrombocytopenia	1998
Evaluation of pyrazoloacridine in patients with advanced pancreatic carcinoma. Investigational new drugs, 1998, Volume: 16, Issue:1 Topics: Acridines; Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Humans; Leukopenia; Male; Middle Aged; Neutropenia; Pancreatic Neoplasms; Pyrazoles; Thrombocytopenia; Treatment Outcome	1998
Phase II study of pyrazoloacridine in metastatic renal cell carcinoma. Investigational new drugs, 2001, Volume: 19, Issue:4 Topics: Acridines; Adult; Aged; Aged, 80 and over; Agranulocytosis; Antineoplastic Agents; Carcinoma, Renal Cell; Drug Evaluation; Humans; Kidney Neoplasms; Lung Neoplasms; Middle Aged; Nausea; Pyrazoles; Thrombocytopenia; Vomiting	2001

Other Studies

1 other study(ies) available for acridines and Thrombopenia

Article	Year
The use of interferon-gamma-treated U937 cells in chemiluminescence assays to detect red cell, platelet and granulocyte antibodies of potential clinical significance. Clinical and laboratory haematology, 1992, Volume: 14, Issue:4 Topics: Acridines; Adult; Autoantibodies; Autoimmune Diseases; Blood Platelets; Erythroblastosis, Fetal; Erythrocytes; Female; Granulocytes; Hemagglutinins; Humans; Hydrogen-Ion Concentration; Immunoglobulin G; Infant, Newborn; Interferon-gamma; Isoantibodies; Luminescent Measurements; Male; Monocytes; Neutropenia; Opsonin Proteins; Phagocytosis; Postpartum Period; Pregnancy; Purpura, Thrombocytopenic, Idiopathic; Receptors, IgG; Recombinant Proteins; Reproducibility of Results; Rho Factor; Sensitivity and Specificity; Thrombocytopenia; Tumor Cells, Cultured	1992

Article

Year

The use of interferon-gamma-treated U937 cells in chemiluminescence assays to detect red cell, platelet and granulocyte antibodies of potential clinical significance.

Clinical and laboratory haematology, 1992, Volume: 14, Issue:4

Topics: Acridines; Adult; Autoantibodies; Autoimmune Diseases; Blood Platelets; Erythroblastosis, Fetal; Erythrocytes; Female; Granulocytes; Hemagglutinins; Humans; Hydrogen-Ion Concentration; Immunoglobulin G; Infant, Newborn; Interferon-gamma; Isoantibodies; Luminescent Measurements; Male; Monocytes; Neutropenia; Opsonin Proteins; Phagocytosis; Postpartum Period; Pregnancy; Purpura, Thrombocytopenic, Idiopathic; Receptors, IgG; Recombinant Proteins; Reproducibility of Results; Rho Factor; Sensitivity and Specificity; Thrombocytopenia; Tumor Cells, Cultured

1992